PRTK - Paratek Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5334.92M
Enterprise value 3201.99M
Trailing P/E N/A
Forward P/E 1-3.52
PEG Ratio (5 yr expected) 1-0.03
Price/sales (ttm)26.56
Price/book (mrq)3.01
Enterprise value/revenue 316.02
Enterprise value/EBITDA 6-2.43

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2017
Most-recent quarter (mrq)31 Mar 2018


Profit margin 0.00%
Operating margin (ttm)-667.40%

Management effectiveness

Return on assets (ttm)-31.06%
Return on equity (ttm)-91.17%

Income statement

Revenue (ttm)12.61M
Revenue per share (ttm)0.44
Quarterly revenue growth (yoy)-44.40%
Gross profit (ttm)-47.46M
EBITDA -82.99M
Net income avi to common (ttm)-89.15M
Diluted EPS (ttm)-3.14
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)184.32M
Total cash per share (mrq)5.83
Total debt (mrq)59.29M
Total debt/equity (mrq)53.53
Current ratio (mrq)8.06
Book value per share (mrq)3.52

Cash flow statement

Operating cash flow (ttm)-72.7M
Levered free cash flow (ttm)-41.43M

Trading information

Stock price history

Beta 0.42
52-week change 3-48.51%
S&P500 52-week change 313.55%
52-week high 329.00
52-week low 39.85
50-day moving average 310.56
200-day moving average 312.80

Share statistics

Avg vol (3-month) 3596.57k
Avg vol (10-day) 3423.99k
Shares outstanding 531.6M
Float 26.19M
% held by insiders 11.49%
% held by institutions 184.62%
Shares Short (15 Jun 2018) 45.03M
Short Ratio (15 Jun 2018) 49.11
Short % of Float (15 Jun 2018) 416.11%
Short % of Shares Outstanding (15 Jun 2018) 415.91%
Shares Short (prior month 15 May 2018) 44.56M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 329 Oct 2014
Ex-dividend date 431 Oct 2014
Last split factor (new per old) 21/12
Last split date 331 Oct 2014